BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 23460808)

  • 21. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
    Su Y; Zhou L; Yu Q; Lu J; Liu W
    Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lead Decreases Bone Morphogenetic Protein-7 (BMP-7) Expression and Increases Renal Cell Carcinoma Growth in a Sex-Divergent Manner.
    Grunz EA; Anderson H; Ernst RM; Price S; Good D; Vieira-Potter V; Parrish AR
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor α and β in esophageal squamous cell carcinoma.
    Zuguchi M; Miki Y; Onodera Y; Fujishima F; Takeyama D; Okamoto H; Miyata G; Sato A; Satomi S; Sasano H
    Cancer Sci; 2012 Jul; 103(7):1348-55. PubMed ID: 22463081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
    Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
    Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
    Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
    Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression.
    Lin CL; Hung TW; Ying TH; Lin CJ; Hsieh YH; Chen CM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
    Teng J; Wang ZY; Jarrard DF; Bjorling DE
    Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
    Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.
    Breuksch I; Welter J; Bauer HK; Enklaar T; Frees S; Thüroff JW; Hasenburg A; Prawitt D; Brenner W
    Cell Commun Signal; 2018 Jun; 16(1):35. PubMed ID: 29954386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
    Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
    PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells.
    Zhao Y; Tang H; Zeng X; Ye D; Liu J
    Biomed Pharmacother; 2018 Feb; 98():36-44. PubMed ID: 29241073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
    Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.